Analysts See $0.52 EPS for LivaNova PLC (LIVN)

April 12, 2018 - By reb123z

LivaNova PLC (NASDAQ:LIVN) Logo

Analysts expect LivaNova PLC (NASDAQ:LIVN) to report $0.52 EPS on May, 2.They anticipate $0.19 EPS change or 26.76 % from last quarter’s $0.71 EPS. LIVN’s profit would be $25.11M giving it 41.47 P/E if the $0.52 EPS is correct. After having $0.88 EPS previously, LivaNova PLC’s analysts see -40.91 % EPS growth. The stock increased 0.56% or $0.48 during the last trading session, reaching $86.26. About 155,544 shares traded. LivaNova PLC (NASDAQ:LIVN) has risen 66.28% since April 12, 2017 and is uptrending. It has outperformed by 54.73% the S&P500.

LivaNova PLC, a medical device company, designs, develops, makes, and sells therapeutic solutions worldwide. The company has market cap of $4.17 billion. It operates in three businesses: Neuromodulation, Cardiac Surgery, and Cardiac Rhythm Management. It currently has negative earnings. The Neuromodulation business designs, develops, and markets its Vagus Nerve Stimulation Therapy System, an implantable device to treat drug-resistant epilepsy and treatment-resistant depression (TRD).

LivaNova PLC (NASDAQ:LIVN) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.